Growth curve analysis of BMI in relation to primary care utilization in prostate cancer survivors

2010 ◽  
Vol 4 (3) ◽  
pp. e183-e189
Author(s):  
Gregory P. Beehler ◽  
Michael Wade ◽  
Lynn Steinbrenner ◽  
Laura O. Wray
2016 ◽  
Vol 10 (5) ◽  
pp. 906-914 ◽  
Author(s):  
Shawna V. Hudson ◽  
Pamela A Ohman-Strickland ◽  
Alicja Bator ◽  
Denalee O’Malley ◽  
Daniel Gundersen ◽  
...  

2014 ◽  
Vol 73 (1) ◽  
pp. 23637 ◽  
Author(s):  
Jon C. Tilburt ◽  
Stacy Kelley ◽  
Christine A. DeCourtney ◽  
Katherine M. Humeniuk ◽  
Jerilyn Latini ◽  
...  

2021 ◽  
Author(s):  
Miho Kimachi ◽  
Kenji Omae ◽  
Tsukasa Kamitani ◽  
Shingo Fukuma

Abstract PurposeGiven the growing diversity among cancer survivors and the fact that oncologists typically do not perform long-term care, the expected role of primary care physicians (PCPs) in cancer survivor care is expanding. However, communication and collaboration between oncologists and PCPs is lacking. Therefore, we assessed the perception of cancer survivor care among PCPs.MethodsWe surveyed 767 Japanese Board-certified PCPs, regardless of facility type (clinics and hospitals), inquiring about PCPs’ perceptions of their role in survivor care. Additionally, we included vignette-based scenarios focused on colorectal and prostate cancer survivors to explore factors associated with their clinical decisions. Results We obtained 91 replies (response rate: 11.9%). A total of 75% of PCPs had encountered at least 1 cancer patient in actual practice. Even for patients actively receiving cancer treatment, >70% of PCPs reported that they were willing to engage in all aspects of survivor care, except for the administration of anticancer drugs. Further, 49% of PCPs considered that both PCPs and oncologists were suited to performing regular screening for cancer recurrence in high-risk patients. Multivariable logistic regression analyses revealed that clinic PCPs were less inclined to conduct screening for recurrence than hospital PCPs in both colorectal (odds ratio, 3.85 [95% confidence interval 1.40-10.6]) and prostate cancer (4.36 [95% confidence interval 1.51-12.6]) scenarios.ConclusionsOur findings suggest that Japanese PCPs are willing to engage in survivor care and encourage closer collaboration between oncologists and PCPs. However, oncologists might need to request cooperation, considering the facility type with which PCPs are affiliated.


Sign in / Sign up

Export Citation Format

Share Document